Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Fen Wang

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2010
Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibitionAntonio Gualberto, Marisa Dolled-Filhart, Mark Gustavson, et al.
Cancer Research|June 3, 2004
Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinaseSridhar K Rabindran, Carolyn M Discafani, Edward C Rosfjord, et al.
Journal of Medicinal Chemistry|February 18, 2005
Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activityHwei-Ru Tsou, Elsebe G Overbeek-Klumpers, William A Hallett, et al.
Journal of Medicinal Chemistry|December 28, 2002
Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)Allan Wissner, Elsebe Overbeek, Marvin F Reich, et al.
Chinese Journal of Integrative Medicine|December 10, 2016
Effect of Shuanghu Qinggan Granule () and Yigan Yiqi Jieyu Granule () plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trialYong-An Ye, De-Lu Tian, Jian Jiang, et al.
Ebiomedicine|October 27, 2018
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndromeBor-Sheng Ko, Yu-Fen Wang, Jeng-Lin Li, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 31, 2025
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference WorkshopsPaul K Wallace, Evan R Jellison, Sherry Thornton, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2010
Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibitionAntonio Gualberto, Marisa Dolled-Filhart, Mark Gustavson, et al.
Cancer Research|June 3, 2004
Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinaseSridhar K Rabindran, Carolyn M Discafani, Edward C Rosfjord, et al.
Journal of Medicinal Chemistry|February 18, 2005
Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activityHwei-Ru Tsou, Elsebe G Overbeek-Klumpers, William A Hallett, et al.
Journal of Medicinal Chemistry|December 28, 2002
Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)Allan Wissner, Elsebe Overbeek, Marvin F Reich, et al.
Chinese Journal of Integrative Medicine|December 10, 2016
Effect of Shuanghu Qinggan Granule () and Yigan Yiqi Jieyu Granule () plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trialYong-An Ye, De-Lu Tian, Jian Jiang, et al.
Ebiomedicine|October 27, 2018
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndromeBor-Sheng Ko, Yu-Fen Wang, Jeng-Lin Li, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 31, 2025
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference WorkshopsPaul K Wallace, Evan R Jellison, Sherry Thornton, et al.
Pageof 8